Clinical Research Services Berlin GmbH

Berlin 13672

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed